Salcedo Mauricio, Taja Lucía, Utrera Dolores, Chávez Pedro, Hidalgo Alfredo, Pérez Carlos, Benítez Luis, Castañeda Cristina, Delgado Ricardo, Gariglio Patricio
Oncology Research Unit, Oncology Hospital, National Medical Center SXXI-IMSS, Mexico.
Int J Exp Pathol. 2002 Dec;83(6):275-86. doi: 10.1046/j.1365-2613.2002.00198.x.
The role of tumour suppressor genes in the development of human cancers has been studied extensively. In viral carcinogenesis, the inactivation of suppressor proteins such as retinoblastoma (pRb) and p53, and cellular oncogenes overexpression, such as c-myc, has been the subject of a number of investigations. In uterine-cervix carcinomas, where high-risk human papillomavirus (HPV) plays an important role, pRb and p53 are inactivated by E7 and E6 viral oncoproteins, respectively. However, little is known about the in situ expression of some of these proteins in pre-malignant and malignant cervical tissues. On the other hand, it has also been demonstrated that c-myc is involved in cervical carcinogenesis, and that pRb participates in the control of c-myc gene expression. By using immunostaining techniques, we investigated pRb immunodetection pattern in normal tissues, squamous intraepithelial lesions (SILs) and invasive carcinomas from the uterine cervix. Our data show low pRb detection in both normal cervical tissue and invasive lesions, but a higher expression in SILs. C-Myc protein was observed in most of the cellular nuclei of the invasive lesions, while in SILs was low. These findings indicate a heterogeneous pRb immunostaining during the different stages of cervical carcinogenesis, and suggest that this staining pattern could be a common feature implicated in the pathogenesis of uterine-cervix carcinoma.
肿瘤抑制基因在人类癌症发生发展中的作用已得到广泛研究。在病毒致癌过程中,诸如视网膜母细胞瘤(pRb)和p53等抑制蛋白的失活以及细胞癌基因如c-myc的过表达,已成为多项研究的主题。在高危人乳头瘤病毒(HPV)起重要作用的子宫颈癌中,pRb和p53分别被E7和E6病毒癌蛋白失活。然而,对于这些蛋白在癌前和恶性宫颈组织中的原位表达情况知之甚少。另一方面,也已证明c-myc参与宫颈癌的发生,并且pRb参与c-myc基因表达的调控。通过使用免疫染色技术,我们研究了子宫颈正常组织、鳞状上皮内病变(SILs)和浸润性癌中pRb的免疫检测模式。我们的数据显示,正常宫颈组织和浸润性病变中pRb的检测率较低,但在SILs中表达较高。在浸润性病变的大多数细胞核中观察到c-Myc蛋白,而在SILs中含量较低。这些发现表明在宫颈癌发生的不同阶段pRb免疫染色存在异质性,并提示这种染色模式可能是子宫颈癌发病机制中的一个共同特征。